| Size: 2 Mo 17th May 2018 Contrôle de la douleur chez nos patients les plus âgés  | Size: 3 Mo 17th May 2018 Depression in the rheumatology clinic: How common is it and what can you do about it?  | Size: 6 Mo 17th May 2018 iGen in a GenX World  | Size: 3 Mo 17th May 2018 Ces petits qui deviendront grands  | Size: 767 Ko 17th May 2018 Everything You Didn’t Want to Know about anti-DNA, and More  | Size: 266 Ko 17th May 2018 Patterns of aspirin use in SLE pregnancies within a multinational inception cohort.  | Size: 697 Ko 17th May 2018 Association between Immunosuppression and Risk of New Onset Interstitial Lung Disease in Systemic Sclerosis  | Size: 2 Mo 17th May 2018 Checkpoint Inhibitors and Immune-Related Adverse Events  | Size: 857 Ko 17th May 2018 SLE AND CANCER: DOUBLE TROUBLE  | Size: 1 Mo 17th May 2018 Low Resting Energy Metabolism, Higher Fat, and Greater Fatigue in Sedentary Patients with RA Cachexia  | Size: 888 Ko 17th May 2018 Biomarker Discoveries in Systemic Rheumatic Diseases (SRD  | Size: 4 Mo 17th May 2018 Building the Arthritis Alliance of Canada Quality Framework: Development of a patient-centered balanced scorecard approach to improve quality of care in rheumatoid arthritis (RA) patients in Canada  | Size: 228 Ko 17th May 2018 Potential communication failures at hospital discharge may compromise SLE care  | Size: 999 Ko 17th May 2018  Thick as Thieves: a Curious Case of Sjögren’s Syndrome  | Size: 2 Mo 17th May 2018 Myosite anti PM-SCL75  | Size: 8 Mo 17th May 2018 Vasculite du système nerveux central à BCG
Next »Page 1 of « Prev


 | Size: 6 Mo 5th Jun 2019 Revelations and Continued Mysteries in Rheumatoid Arthritis  | Size: 9 Mo 5th Jun 2019 How Useful is Ultrasound in RA  | Size: 5 Mo 5th Jun 2019 Mise à jour sur les vasculites systémiques des petits vaisseaux (VPV)  | Size: 5 Mo 5th Jun 2019 Giant cell arteritis: are we moving beyond a biopsy?  | Size: 10 Mo 5th Jun 2019 The Treatment of Systemic Lupus Erythematosus – Past Imperfect; Future Tense  | Size: 2 Mo 5th Jun 2019 Lupus: A Case of Female Discrimination  | Size: 135 Ko 17th Sep 2026 The Differential Expression of CLEC12A on Neutrophils of Rheumatoid arthritis Patients Correlates with Clinical Parameters.  | Size: 137 Ko 17th Sep 2026 JAK Inhibitors: a Promising Molecular-Targeted Therapy in Dermatomyositis.  | Size: 138 Ko 17th Sep 2026 Severe Axial and Pelvi-femoral Muscle Damage in Immune-Mediated Necrotizing Myopathy evaluated by Whole-body MRI.  | Size: 133 Ko 17th Sep 2026 Association Between Immunosuppressive Therapy and Course of Mild Interstitial Lung Disease in Systemic Scleroderma.  | Size: 135 Ko 17th Sep 2026 No Time to Lose: A Case of Severe Multifocal Aneurysmal Vasculitis.  | Size: 134 Ko 17th Sep 2026 Clinical Significance of Raynaud Phenomenon in Systemic Lupus Erythematosus.  | Size: 135 Ko 17th Sep 2026 Effects of Strength Training on Participation and Health Related Quality of Life in Rheumatoid Arthritis.  | Size: 135 Ko 17th Sep 2026 Comparison of first biologic drug persistence in patients with ankylosis spondylitis and non-radiographic axial spondyloarthritis: data from the SPARCC registry.  | Size: 136 Ko 17th Sep 2026 Identifying Barriers and Facilitators to Physical Activity for People with Scleroderma: A Nominal Group Technique Study.  | Size: 136 Ko 17th Sep 2026 Probability of Achieving Low Disease Activity or Remission in Subjects With Active Psoriatic Arthritis Treated With Apremilast.  | Size: 137 Ko 17th Sep 2026 Achievement of cDAPSA Low Disease Activity or Remission Is Associated With Control of Articular and Extra-Articular Manifestations of Active Psoriatic Arthritis in Subjects Treated With Apremilast.  | Size: 138 Ko 17th Sep 2026 Low Interstitial Lung Disease Event Rate in Patients with Rheumatoid Arthritis: Pooled Post Hoc Analysis of Data from the Tofacitinib Clinical Development Program.  | Size: 139 Ko 17th Sep 2026 Physical Activity Monitoring using Wrist-Worn Accelerometer in the Assessment of Patients with Myositis.  | Size: 135 Ko 17th Sep 2026 Stressful Life Events are Relation to RA Diagnosis and Presenting Characteristics: Results from the Canadian Early Arthritis Cohort (CATCH).
Next »Page 1 of « Prev


Conférence reportée à 2021

Voir la page Mes Fichiers

Voir la page Mes Fichiers